What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Virus
The scientist’s investigation covers issues in Internal medicine, Outbreak, Randomized controlled trial, Virology and Epidemiology.
His Outbreak research focuses on subjects like Microbiology, which are linked to Population Risk.
His Randomized controlled trial research is multidisciplinary, incorporating elements of Informed consent, Pneumonia, Intervention, Adverse effect and Placebo.
He has researched Pneumonia in several fields, including Lopinavir, Viral load, Coronavirus and Intention-to-treat analysis.
His Virology study often links to related topics such as Betacoronavirus.
The Rate ratio study combines topics in areas such as Lung injury, Randomization, Dexamethasone and Respiratory failure.
His most cited work include:
- A novel coronavirus outbreak of global health concern. (2669 citations)
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. (2624 citations)
- Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
What are the main themes of his work throughout his whole career to date?
Peter Horby mainly focuses on Virology, Internal medicine, Outbreak, Pandemic and Immunology.
His research in Confidence interval, Mechanical ventilation, Coronavirus disease 2019, Relative risk and Odds ratio are components of Internal medicine.
The concepts of his Odds ratio study are interwoven with issues in Prospective cohort study and Cohort study.
His study explores the link between Outbreak and topics such as Public health that cross with problems in Family medicine.
His Pandemic research incorporates themes from Global health, Epidemiology and Intensive care medicine.
Peter Horby works mostly in the field of Ebola virus, limiting it down to topics relating to Clinical trial and, in certain cases, Research design and Randomized controlled trial, as a part of the same area of interest.
He most often published in these fields:
- Virology (22.92%)
- Internal medicine (21.53%)
- Outbreak (17.01%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (21.53%)
- Coronavirus disease 2019 (8.33%)
- Outbreak (17.01%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Coronavirus disease 2019, Outbreak, Pandemic and Intensive care medicine.
His work on Severe acute respiratory syndrome coronavirus 2 as part of general Coronavirus disease 2019 research is frequently linked to Economic impact analysis, thereby connecting diverse disciplines of science.
His Outbreak research is included under the broader classification of Virology.
His Pandemic study incorporates themes from Global health, Public health, Observational study and Family medicine.
He has included themes like Clinical research and Clinical trial in his Intensive care medicine study.
His Randomized controlled trial research is multidisciplinary, relying on both Odds ratio and Prospective cohort study.
Between 2018 and 2021, his most popular works were:
- A novel coronavirus outbreak of global health concern. (2669 citations)
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. (2624 citations)
- Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
